Interest Pushes Humira Award Up To $1.85B

Law360, New York (December 18, 2009, 4:30 PM EST) -- A federal judge has ordered Abbott Laboratories to pay Centocor Ortho Biotech Inc. interest of nearly $176 million on the record $1.67 billion judgment he awarded the Johnson & Johnson unit after a jury found that Abbott's arthritis drug Humira infringed a Centocor patent.

In a final judgment entered Friday in the U.S. District Court for the Eastern District of Texas, Judge T. John Ward said he calculated the interest beginning on the date the patent-in-suit was issued, July 4, 2006, using the average 90-day commercial...
To view the full article, register now.